Nicaise Claude 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Nicaise Claude
Director
Transactions
- Award
Common Stock
2025-03-10+2,383→ 20,557 total - Award
Stock Options (right to buy)
2025-03-10+4,792→ 20,557 totalExercise: $99.69From: 2026-03-10Exp: 2035-03-10→ Common Stock (4,792 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.